Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma

被引:10
|
作者
Jinato, Thananya [1 ,2 ]
Anuntakarun, Songtham [1 ]
Satthawiwat, Nantawat [1 ]
Chuaypen, Natthaya [1 ]
Tangkijvanich, Pisit [1 ]
机构
[1] Chulalongkorn Univ, Fac Med, Ctr Excellence Hepatitis & Liver Canc, Dept Biochem, Bangkok 10330, Thailand
[2] Chulalongkorn Univ, Fac Med, Philosophy Program Med Sci, Grad Affairs, Bangkok, Thailand
关键词
Gut dysbiosis; HCC; Viral hepatitis; NAFLD; 16 s rRNA; Biomarker; FATTY LIVER-DISEASE; INTESTINAL MICROBIOME; METAANALYSIS; ALCOHOL;
D O I
10.1007/s00253-023-12845-1
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Altered gut microbiota has been connected to hepatocellular carcinoma (HCC) occurrence and advancement. This study was conducted to identify a gut microbiota signature in differentiating between viral-related HCC (Viral-HCC) and non-hepatitis B-, non-hepatitis C-related HCC (NBNC-HCC). Fecal specimens were obtained from 16 healthy controls, 33 patients with viral-HCC (17 and 16 cases with hepatitis B virus (HBV) and hepatitis C virus (HCV) infection, respectively), and 18 patients with NBNC-HCC. Compositions of fecal microbiota were assessed by 16S rRNA sequencing. Bioinformatic analysis was performed by the DADA2 pipeline in the R program. Significantly different genera from the top 50 relative abundance were used to classify between subgroups of HCC by the Random Forest algorithm. Our data demonstrated that the HCC group had a significantly decreased alpha-diversity and changed microbial composition in comparison with healthy controls. Within the top 50 relative abundance, there were 11 genera including Faecalibacterium, Agathobacter, and Coprococcus that were significantly enhanced in Viral-HCC, while 5 genera such as Bacteroides, Streptococcus, Ruminococcus gnavus group, Parabacteroides, and Erysipelatoclostridium were enhanced in NBNC-HCC. Compared to Viral-HCC, the NBNC-HCC subgroup significantly reduced various short-chain fatty acid-producing bacteria, as well as declined fecal butyrate but elevated plasma surrogate markers of microbial translocation. Based on the machine learning algorithm, a high diagnostic accuracy to classify HCC subgroups was achieved with an area under the receiver-operating characteristic (ROC) curve (AUC) of 0.94. Collectively, these data revealed that gut dysbiosis was distinct according to etiological factors of HCC, which might play an essential role in hepatocarcinogenesis. These findings underscore the possible use of a gut microbiota signature for the diagnosis and therapeutic approaches regarding different subgroups of HCC. Key points center dot Gut dysbiosis is connected to hepatocarcinogenesis and can be used as a novel biomarker. center dot Gut microbiota composition is significantly altered in different etiological factors of HCC. center dot Microbiota-based signature can accurately distinguish between Viral-HCC and NBNC-HCC.
引用
收藏
页码:21 / 21
页数:1
相关论文
共 50 条
  • [31] AUTOANTIBODIES IN VIRAL HEPATITIS-RELATED HEPATOCELLULAR-CARCINOMA
    IMAI, H
    KIYOSAWA, K
    CHAN, EKL
    TAN, EM
    INTERVIROLOGY, 1993, 35 (1-4) : 73 - 85
  • [32] Non-viral hepatocellular carcinoma: Non alcoholic fatty liver disease related versus alcoholic
    Taniguchi, M
    Nakagawa, H
    Asaoka, Y
    Tani, M
    Sasaki, J
    Saito, Y
    Imamura, M
    Toda, N
    Tagawa, K
    GASTROENTEROLOGY, 2003, 124 (04) : A746 - A747
  • [33] NASH CIRRHOSIS: DISTINCT PHENOTYPICAL DIFFERENCES, MORE SYSTEMIC INFLAMMATION, AND MORE FRAIL THAN VIRAL- RELATED CIRRHOSIS
    Wong, Yu Jun
    Tan, Heng Yi
    Yap, Siew Yoon
    Lim, Geraldine
    Khoo, Seok Hwee
    Tan, Jessica
    Kumar, Rahul
    Khoo, Joan
    Barbara, Rosario Helen
    Hutchinson, Paul Edward
    HEPATOLOGY, 2023, 78 : S847 - S847
  • [34] HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN US PATIENTS WITH VIRAL OR NON-VIRAL ETIOLOGY OF CIRRHOSIS
    Mair, Robert D.
    Valenzuela, Antonia
    Ha, Nghiem B.
    Ahmed, Aijaz
    Ayoub, Walid S.
    Daugherty, Tami
    Lutchman, Glen A.
    Garcia, Gabriel
    Cooper, Allen D.
    Keeffe, Emmet B.
    Nguyen, Mindie H.
    HEPATOLOGY, 2011, 54 : 1414A - 1414A
  • [35] INSULIN USE IS RELATED TO THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA AT YOUNGER AGE WITH NON-VIRAL ETIOLOGY
    Tateishi, R.
    Okanoue, T.
    Okita, K.
    Kiyosawa, K.
    Omata, M.
    Kumada, H.
    Hayashi, N.
    Koike, K.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S260 - S260
  • [36] Study on the anti-tumor mechanism related to immune microenvironment of Bombyx Batryticatus on viral and non-viral infections of hepatocellular carcinoma
    Yuan, Lingyan
    Bing, Zhitong
    Han, Jiani
    An, Xiaoli
    Liu, Xingkui
    Li, Rui
    Wang, Caiyun
    Sun, Xueqiang
    Yang, Lei
    Yang, Kehu
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 124
  • [37] Biochemical overview of the recent findings on the correlation between viral hepatitis and its related hepatocellular carcinoma
    Shuchang Lou
    Weili Sun
    Yuan Wu
    Oncology and Translational Medicine, 2018, 4 (06) : 229 - 233
  • [38] Association Between Viral Replication Activity and Postoperative Recurrence of HBV-Related Hepatocellular Carcinoma
    Heo, Subin
    Yang, Jiwon
    Park, Jeayeon
    Hui, Rex Wan-Hin
    Song, Byeong Geun
    Song, In-Hye
    Yoon, Young-In
    Cheung, Tan-To
    Chung, Sung Won
    Choi, Jonggi
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Seto, Wai-Kay
    Lee, Jeong-Hoon
    Choi, Won-Mook
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025,
  • [39] A Systematic Review of the Impact of Resveratrol on Viral Hepatitis and Chronic Viral Hepatitis-related Hepatocellular Carcinoma
    Darvishi, Mohammad
    Nouri, Majid
    Rahimi, Rasoul
    Heidari-Soureshjani, Saeid
    Rafsanjani, Seyed Mahmoud Reza Hashemi
    CURRENT MOLECULAR MEDICINE, 2024,
  • [40] Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma
    Qisha Liu
    Fan Li
    Yaoyao Zhuang
    Jian Xu
    Jianwei Wang
    Xuhua Mao
    Yewei Zhang
    Xingyin Liu
    Gut Pathogens, 11